510(k) K181002

Atellica IM BRAHMS Procalcitonin (PCT) by Siemens Healthcare Diagnostics, Inc. — Product Code PMT

K181002 is an FDA 510(k) premarket notification submitted by Siemens Healthcare Diagnostics, Inc. for the device "Atellica IM BRAHMS Procalcitonin (PCT)". The FDA issued a decision of Substantially Equivalent on Jul 16, 2018. The device falls under product code PMT (Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens), a Class II device regulated under 21 CFR 866.3215. Siemens Healthcare Diagnostics, Inc. has 246 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 16, 2018
Date Received
Apr 16, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens
Device Class
Class II
Regulation Number
866.3215
Review Panel
MI
Submission Type
510(k)

An assay used to determine the level of procalcitonin (PCT) in human serum and plasma as an aid in assessing the mortality for patients diagnosed with severe sepsis or septic shock.

Need the full FDA record for Siemens Healthcare Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K181002. Report a data issue: hello@regdatalab.com.